Mounting evidence of irregularities and rigged rules has emerged through state and local investigations, court decisions, financial disclosure, and audits in the 14 months since the election.
Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs), the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was led, and then asked for an extra 20 years to fully comply.